ALLISON KINYON: Open Payments
NPI 1790161891 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 16 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $80 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $65 |
| Exact Sciences Corporation | 3 | $48 |
| ABBVIE INC. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Medtronic, Inc. | 1 | $22 |
| Corium, LLC | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: MOUNJARO, VRAYLAR, The Cologuard Plus Collection Kit, INGREZZA, MINIMED 780G, Azstarys, NURTEC ODT, REXULTI.
Industry payments across IN — which companies pay providers there.
